<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210524051390N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-01</date_registration>
      <primary_sponsor>Riphah International University, Lahore.</primary_sponsor>
      <public_title>Assessing the effects of Injury Prevention Program on speed, agility and power among cricket players; A Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>Assessing the effects of Injury Prevention Program on speed, agility and power among cricket players; A Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-01-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56541</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: The fishbowl method will be used for randomization. Name of the participants will be written on the pieces of paper and picked randomly, Blinding description: The study will be single-blind as the assessor of the study will be kept blind about the allocation of patients to the treatment group. Blinding will be done by collecting the baseline data from an outcome assessor before randomization.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Speed, Agility and Power.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This group will receive the FIFA 11+program as pre-training exercises for 20 minutes before training sessions and for 10 minutes as post-training exercises after training sessions, two times per week for 3 weeks. Subjects will perform at least a 5-minute self-paced general warm-up  as a baseline treatment consisting of low- to moderate-intensity aerobic exercise including 3 minutes of forward jogging, 1minute of sidestepping, and 1 minute of jogging backwards. Intervention 2: Control group: This group will receive a designated static stretching protocol followed by a dynamic stretching protocol. Each protocol consists of 15 minutes each. The static stretching and dynamic stretching exercises will be repeated 2 times on each leg and will be performed for a duration of 30 seconds with 10-second recovery period between each exercise. The targeted muscles will be plantar flexors, adductors, hamstrings, hip extensors and quadriceps. Subjects will perform at least a 5-minute self-paced general warm-up  as a baseline treatment consisting of low- to moderate-intensity aerobic exercise including 3 minutes of forward jogging, 1minute of sidestepping, and 1 minute of jogging backwards.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
EFFECTS OF INJURY PREVENTION PROGRAM ON SPEED, AGILITY AND POWER AMONG CRICKET PLAYERS. A CLINICAL TRIAL and all collected deidentified IPD will be shared.

When:
After Publication

To whom:
people working in academic institutions and researchers

Conditions:
on permission from investigator

Where to obtain:
Through email to Investigator Raxster93@gmail.com

How to obtain:
Through email to Investigator Raxster93@gmail.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Muzna Munir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Madar-e-Millat Road, Quaid-e-Azam Industrial Estate Quaid e Azam Industrial Estate, Lahore, Punjab</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 42 111 747 424</telephone>
        <email>muzna.munir@riphah.edu.pk</email>
        <affiliation>Riphah International University, Lahore.</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Muzna Munir</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Madar-e-Millat Road, Quaid-e-Azam Industrial Estate Quaid e Azam Industrial Estate, Lahore, Punjab</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 42 111 747 424</telephone>
        <email>muzna.munir@riphah.edu.pk</email>
        <affiliation>Riphah International University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>14-35 years of age.
Male athletes.
Athletes who have never participated in injury prevention program.</inclusion_criteria>
      <agemin>14 years</agemin>
      <agemax>35 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>A medical history of lower extremity injury that required medical attention in the past 6 months.
Any systemic disorder, CVS disease, neurological disorder, bone fracture, or surgery in the previous year.
Any psychosocial impairments that can hinder the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Y93.69</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Activity, other involving other sports and athletics played as a team or group</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This group will receive the FIFA 11+program as pre-training exercises for 20 minutes before training sessions and for 10 minutes as post-training exercises after training sessions, two times per week for 3 weeks. Subjects will perform at least a 5-minute self-paced general warm-up  as a baseline treatment consisting of low- to moderate-intensity aerobic exercise including 3 minutes of forward jogging, 1minute of sidestepping, and 1 minute of jogging backwards.</i_keyword>
      <i_keyword>Control group: This group will receive a designated static stretching protocol followed by a dynamic stretching protocol. Each protocol consists of 15 minutes each. The static stretching and dynamic stretching exercises will be repeated 2 times on each leg and will be performed for a duration of 30 seconds with 10-second recovery period between each exercise. The targeted muscles will be plantar flexors, adductors, hamstrings, hip extensors and quadriceps. Subjects will perform at least a 5-minute self-paced general warm-up  as a baseline treatment consisting of low- to moderate-intensity aerobic exercise including 3 minutes of forward jogging, 1minute of sidestepping, and 1 minute of jogging backwards.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Speed. Timepoint: before intervention and then at the end of 3rd week. Method of measurement: 30m Sprint Test.</prim_outcome>
      <prim_outcome>Agility. Timepoint: before intervention and then at the end of 3rd week. Method of measurement: T- Drill Test.</prim_outcome>
      <prim_outcome>Power. Timepoint: before intervention and then at the end of 3rd week. Method of measurement: 5 Jumps Test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Riphah International University, Lahore</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-12-24</approval_date>
        <contact_name>Research &amp; Ethics Committee</contact_name>
        <contact_address>Madar-e-Millat Road, Quaid-e-Azam Industrial Estate Quaid e Azam Industrial Estate, Lahore, Punjab Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
